109685 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Inhibition of pathological angiogenesis in vivo
#902Drug comprising as the active ingredient proliferative vector containing survivin promoter
#903SYSTEM FOR RAPID PRODUCTION OF HIGH-TITER AND REPLICATION-COMPETENT ADENOVIRUS-FREE RECOMBINANT ADENOVIRUS VECTORS
#904Oncolytic adenovirus armed with therapeutic genes
#905CARDIAC ARRHYTHMIA TREATMENT METHODS AND BIOLOGICAL PACEMAKER
#906Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#907Recombinant protein production in a human cell
#908Metastatic colon cancer specific promoter and uses thereof
#909Recombinant adenoviruses preparation and adenovirus banks
#910METHODS OF COMPOSITIONS FOR THE TREATMENT OF OCULAR DISEASES
#911Adenoviral vector-based malaria vaccines
#912REDUCTION OF DERMAL SCARRING
#913Methods for treating pain
#914ANTIFIBROTIC THERAPY
#915Application of heparin-binding epidermal growth factor-like growth factor for medical purposes
#916Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#917Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector
#918Engineered Dendritic Cells and Uses for the Treatment of Cancer
#919Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#920Multivalent vaccines comprising recombinant viral vectors
#921Tumor-targeting gene-virus zd55-il 24,its construction method and application thereof
#922Compositions Comprising a Recombinant Adenovirus and an Adjuvant
#923Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#924NOVEL RECOMBINANT ADENOVIRUS VECTOR HAVING A REDUCED SIDE EFFECT
#925METHOD OF ELICITING IMMUNE RESPONSE
#926Pan cancer oncolytic vectors and methods of use thereof
#927Compositions comprising viruses and methods for concentrating virus preparations
#928Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
#929Articular cartilage gene therapy with recombinant vector encoding BMP-7
#930SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS
#931RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE
#932Uniform field magnetization and targeting of therapeutic formulations
#933TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY IN VIVO GENE DELIVERY
#934Adenoviral vectors having a protein IX deletion
#935Modified Adenovirus Hexon Protein and Uses Thereof
#936Compositions and methods for generating and screening adenoviral libraries
#937Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#938Compositions and methods for the therapy and diagnosis of lung cancer
#939Specific Inhibition of Autoimmunity and Diseases Associated With Autoantigens
#940Therapy for primary and metastatic cancers
#941Adenoviral vectors for influenza virus production
#942Nell-1 enhanced bone mineralization
#943Adenoviral fiber exchange shuttle system
#944Materials and methods for treating ocular-related disorders
#945CANCER TREATMENT BY METABOLIC MODULATIONS
#946Antibody Gene Transfer and Recombinant AAV Therefor
#947Hepatitis C virus nucleic acid vaccine
#948Chromosome 3p21.3 genes are tumor suppressors
#949Stocks of replication-deficient adenovirus
#950ADENOVIRUS VECTOR AND METHOD TO MANIPULATE THE ADENOVIRUS GENOME
#951High-efficiency wild-type-free AAV helper functions
#952Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator
#953Screening tool for antiviral agents
#954Helper virus-free AAV production
#955Methods and compositions for increased transgene expression
#956Touch screens with transparent conductive material resistors
#957Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
#958Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
#959CHROMATOGRAPHIC METHODS FOR ASSESSING ADENOVIRUS PURITY
#960Adenoviral vectors having a protein IX deletion
#961Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours
#962COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#963Oncolytic Adenovirus Armed with Therapeutic Genes
#964HIV vaccines based on Env of multiple clades of HIV
#965Recombinant Adenovirus Expressing A Gene Encoding Streptolysin O Proetin and Anti-Cancer Composition Comprising Same
#966Disease Prevention and Vaccination Prior to Thymic Reactivation
#967Methods and compositions for modulating vascular integrity
#968Recombinant protein production in a human cell
#969Sars Virus Vaccine with Adenovirus Carrier and Preparation Method Thereof, and Use of Sars Virus S Gene for Preparation of Vaccine
#970COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#971LOCALIZED MYOCARDIAL INJECTION METHOD FOR TREATING ISCHEMIC MYOCARDIUM
#972Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby
#973Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations
#974Method and reagents for the enhancement of virus transduction in the bladder epithelium
#975Recombinant virus comprising an intact tumor-therapeutic antibody with human constant regions and the use thereof
#976Method for propagating adenoviral vectors encoding inhibitory gene products
#977Tumor-Specific Vector for Gene Therapy
#978Recombinant viral-based malaria vaccines
#979Vectors for tissue-specific replication
#980Systemic viral/ligand gene delivery system and gene therapy
#981Cancer-targeted viral vectors
#982Stable adenoviral vectors and methods for propagation thereof
#983Vaccine Against Sars
#984Adenoviral vectors and uses thereof
#985Means and methods for producing adenovirus vectors
#986Complementing cell lines
#987Compositions comprising viruses and methods for concentrating virus preparations
#988Novel Methods for Producing Adenoviral Vector Preparations with Reduced Replication-Competent Adenovirus Contamination and Novel Adenoviral Vectors and Preparations
#989Vaccine Against Pandemic Strains Of Influenza Viruses
#990Adenoviral vectors having a protein IX deletion
#991Focal calcium channel modulation
#992Combined gene therapy for the treatment of macroscopic gliomas
#993Materials and Methods for Prevention and Treatment of RNA Viral Diseases
#994ADENOVIRAL VECTORS HAVING A PROTEIN IX DELETION
#995Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#996Serotype of adenovirus and uses thereof
#997Treatment of parkinson's disease and related disorders
#998Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#999METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS
#1000Methods and compositions for gene inactivation
#1001Settings for recombinant adenoviral-based vaccines
#1002Packaging systems for human recombinant adenovirus to be used in gene therapy
#1003Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#1004Compositions Comprising Viruses and Methods for Concentrating Virus Preparations
#1005Selective induction of apoptosis to treat ocular disease by expression of PEDF
#1006Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
#1007Methods of adenovirus purification
#1008Oncolytic adenoviral vectors encoding GM-CSF
#1009Transient protein expression methods
#1010Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#1011Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#1012Methods of treating restenosis
#1013SHIELDED ADENOVIRAL VECTORS AND METHODS OF USE
#1014Liquid adenovirus formulations
#1015HUMAN MATRIX METALLOPROTEINASE-8 GENE DELIVERY ENHANCES THE ONCOLYTIC ACTIVITY OF A REPLICATING ADENOVIRUS
#1016METHODS AND COMPOSITIONS FOR GENE THERAPY
#1017Human cytomegalovirus immunotherapy
#1018Vectors for tissue-specific replication
#1019Formulation for adenovirus storage
#1020Methods for treating cancers and restenosis with P21
#1021Long lasting drug formulations
#1022Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#1023HIV-1 Clade A consensus sequences, antigens, and transgenes
#1024Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome
#1025METHODS OF POLYPEPTIDE PRODUCTION
#1026Adenoviruses mutated in the VA genes for cancer treatment
#1027Compositions comprising viruses and methods for concentrating virus preparations
#1028Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#1029Vectors for tissue-specific replication
#1030Method of treating fibrosis
#1031REGULATORY ELEMENTS FOR DELIVERY TO THE LIVER
#1032METHOD OF USING ADENOVIRAL VECTORS WITH INCREASED IMMUNOGENICITY IN VIVO
#1033Adenoviral Vector Compositions
#1034Method for the production and purification of adenoviral vectors
#1035Protamine-Adenoviral Vector Complexes and Methods of Use
#1036Methods and Compositions for Protein Production Using Adenoviral Vectors
#1037Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
#1038Methods and means for producing proteins with predetermined post-translational modifications
#1039TELOMELYSIN/GFP-EXPRESSING RECOMBINANT VIRUS
#1040Biomarkers for Bladder Cancer
#1041ADENOVIRUS FIBER SHAFT COMPOSITION AND METHODS OF USE
#1042Adenoviral Amplicon and Producer Cells for the Production of Replication-Defective Adenoviral Vectors, Methods of Preparation and Use Thereof
#1043Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same
#1044Combinatorial Methods For Inducing Cancer Cell Death
#1045Epas1 Gene Transfer to Improve Cell Therapy
#1046Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#1047Treatment of diabetes with synthetic beta cells
#1048Tmprss2 Regulatory Sequences and Uses Thereof
#1049Ocular Tissue Modification
#1050MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease
#1051Recombinant Vaccine Against Japanese Encephalitis Virus (Jev) Infection and a Method Thereof
#1052Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#1053Chimeric adenoviral vectors
#1054Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity
#1055Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease
#1056Adenoviral vectors having a protein IX deletion
#1057Anti-Tumor Activity of an Oncolytic Adenovirus-Delivered Oncogene siRNA
#1058Gene therapy using replication competent targeted adenoviral vectors
#1059RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE
#1060Adenoviral expression vectors
#1061Methods and compositions to induce antitumor response
#1062Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#1063Over-expression of enzymes involved in post-translational protein modifications in human cells
#1064Immunization regimen with E4-deleted adenovirus prime and E1-deleted adenovirus boost
#1065PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY
#1066Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
#1067Viral vector driven mutant bacterial cytosine deaminase gene and uses thereof
#1068Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells
#1069Polyvalent Viral Vectors and a System for Production Thereof
#1070Targeting adenoviral vectors to dendritic cells
#1071Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#1072Method of Using Adenoviral Vectors to Induce an Immune Response
#1073METHOD OF MODULATING VASCULARIZATION
#1074Targeted Vectors
#1075Gene Delivery System Containing Relaxin Gene And Pharmaceutical Composition Using Relaxin
#1076Recombinant p53 adenovirus methods and compositions
#1077Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#1078Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient
#1079Immunization of avians by administration of non-replicating vectored vaccines
#1080Methods for the Production and Purification of Adenoviral Vectors
#1081Adenovirus-transfected primary cells and methods of pathway mapping
#1082Adept or gdept producing acetaldehyde
#1083Autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells
#1084Self-rearranging DNA vectors
#1085Drug for preventing or treating heart diseases comprising CD9 gene
#1086Method for the production and purification of adenoviral vectors
#1087Compositions and methods for the therapy and diagnosis of lung cancer
#1088HYALURONIC ACID MEDIATED ADENOVIRAL TRANSDUCTION
#1089Composition for the preservation of viruses
#1090Decoy-containing pharmaceutical compositions and method of using the same
#1091Adenovirus packaging cell lines
#1092Methods of gene therapy for treating disorders of the ear by adminstering a vector encoding an antonal-associated factor
#1093Cancer gene therapeutic drug
#1094Method for selective expression of therapeutic genes by hyperthermia
#1095Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals
#1096Cancer gene therapeutic drug
#1097Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein
#1098Adenoviral vectors having a protein IX deletion
#1099Recombinase-Based System for Expression of Foreign Proteins Using Adenovirus Vectors
#1100Replication competent viruses capable of silencing virus inhibitory factor expression
#1101COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS
#1102Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase
#1103Methods and means for producing proteins with predetermined post-translational modifications
#1104Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
#1105Novel use of adenoviruses and nucleic acids that code for said viruses
#1106Immunotherapy
#1107Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
#1108MATERIALS AND METHODS FOR TREATING OCULAR-RELATED DISORDERS
#1109hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes
#1110Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use
#1111Use of receptor sequences for immobilizing gene vectors on surfaces
#1112Recombinant viral-based malaria vaccines
#1113Vectors for tissue-specific replication
#1114Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications
#1115Inhibition of pathological angiogenesis in vivo
#1116Gutless adenovirus vector and the construction method thereof
#1117Regulation of angiogenesis with zinc finger proteins
#1118Production of vaccines
#1119C/CLP antagonists and methods of use thereof
#1120Recombinant viral-based malaria vaccines
#1121Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
#1122Antibody fragment-targeted immunoliposomes for systemic gene delivery
#1123Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
#1124Compositions and methods of using angiopoietin-like 4 protein
#1125Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications
#1126Recombinant protein production in a human cell
#1127Gene modulation by rb2/p130 expression
#1128METHOD OF TREATING FIBROSIS
#1129Carcinoembryonic antigen (CEA) peptides
#1130Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor
#1131Serotype of adenovirus and uses thereof
#1132Use of calcium binding proteins to improve cardiac contractile function
#1133Ruminant feed containing N-carbamoyl glutamate
#1134Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same
#1135Methods and compositions for in vivo inflammation monitoring
#1136Tarp promoter and uses thereof
#1137Recombinant adenoviral vector and method of use
#1138Polynucleotides for use in recombinant adeno-associated virus virion production
#1139Glucose inducible insulin expression and methods of treating diabetes
#1140Adenovirus vectors comprising meganuclease-type endonucleases, and related systems
#1141Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
#1142Methods and compositions for the inhibition of stat5 in prostate cancer cells
#1143Gene transfer with adenoviruses having modified fiber proteins
#1144Adenoviral vectors having a protein IX deletion
#1145Nucleic acid delivery
#1146Compositions and methods involving MDA-7 for the treatment of cancer
#1147Compositions and methods for the therapeutic treatment of diabetes
#1148Modified fiber proteins for efficient receptor binding
#1149Vaccines for the rapid response to pandemic avian influenza
#1150Addition of transgenes into adenoviral vectors
#1151MDA-7 protein variants having antiproliferative activity
#1152Adenoviral vectors for treating diseases
#1153Adenoviral vector-based vaccines
#1154Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
#1155Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#1156Method and compositions for treating hepatocellular cancer
#1157Methods for immunotherapy of cancer
#1158Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
#1159Methods and compositions for modulating vascular integrity
#1160Novel inhibitor of angiogenesis, tumor progression, and metastasis targeting ras signalling pathway
#1161Capsid-modified adenovirus vectors and methods of using the same
#1162Recombinant modified adenovirus fiber protein
#1163HIV vaccines based on Env of multiple clades of HIV
#1164Novel method for the protection and purification of adenoviral vectors
#1165Conditionally replicating viruses and methods for cancer virotherapy
#1166Adenoviral vectors having a protein IX deletion
#1167Cell lines for production of replication-defective adenovirus
#1168Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
#1169Method of accelerated vaccination against Ebola viruses
#1170Modulation of cytokine signaling regulators and applications for immunotherapy
#1171Mule: Mcl-1 ubiquitination ligase E3
#1172Pharmaceutical composition containing decoy and use of the same
#1173Recombinant porcine adenovirus vector
#1174Novel virus vector
#1175Adenoviral vectors for treating diseases
#1176Adenoviral vectors for treating diseases
#1177Therapeutic regimen for treating cancer
#1178Ocular gene therapy
#1179Packaging systems for human recombinant adenovirus to be used in gene therapy
#1180Compounds and methods for inhibiting hepatitis C virus replication
#1181Method of treating a disorder by suicide gene therapy
#1182Methods for treating cancers and restenosis with p21
#1183Methods and compositions for the treatment of ocular diseases
#1184Rhesus HER2/neu, nucleotides encoding same, and uses thereof
#1185Adenoviral vectors having a protein IX deletion
#1186Recombinant adenoviral vectors and applications thereof
#1187Compounds promoting delivery of genes
#1188Use of adenoviruses mutated in the VA genes for cancer treatment
#1189Human prolyl isomerase 1 (PIN 1) promoter and uses thereof
#1190Modified adenoviral fiber with ablated to cellular receptors
#1191Therapeutic immunization of hiv-infected individuals
#1192Methods and compositions for efficient gene transfer using transcomplementary vectors
#1193Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
#1194Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
#1195Formulations for therapeutic viruses having enhanced storage stability
#1196Adeno-associated virus materials and methods
#1197Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#1198Use of the sodium iodine symporter to effect uptake of iodine
#1199Novel prostate tumor-specific promoter
#1200Viral agents